Lessons from Novo Nordisk on the stampede for obesity drugs

Paul Ingram, who manages a ranch in rural Texas, is not the type you would normally associate with a weight-loss fad. But a year ago he finally got fed up with lugging his 320lb (145kg) frame around all day in the heat. His family has a history of heart disease. As a result of covid-19, he had become painfully aware of the risks of obesity. His efforts to lose weight through diet and exercise had gone nowhere. “I needed some help.”

Listen to this story. Enjoy more audio and podcasts on iOS or Android.

Your browser does not support the <audio> element.

So his

→ Continue reading at The Economist

Similar Articles

Advertisment

Most Popular